Another armed CD4⁺ T cell ready to battle hepatocellular carcinoma^†‡

• Pages: 1-3
• First Published: 08 March 2013

Furthering the understanding of maternal obesity in nonalcoholic fatty liver disease^†‡§

• Pages: 4-5
• First Published: 15 March 2013

In the eye of the B-holder: Natural history of chronic hepatitis B^†‡

• Pages: 6-8
• First Published: 04 March 2013

The new front-line in hepatitis B/D research: Identification and blocking of a functional receptor^†‡

• Pages: 9-12
• First Published: 06 February 2013

Hepatic gene therapy using lentiviral vectors: Has safety been established?^†‡

• Pages: 13-14
• First Published: 20 May 2013

Avoiding idiosyncratic DILI: Two is better than one^†‡

• Pages: 15-17
• First Published: 06 February 2013

Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?^†‡

• Pages: 18-20
• First Published: 11 February 2013

Causes of death in patients with hepatitis B: A natural history cohort study in the United States^†‡

• Pages: 21-30
• First Published: 18 October 2012

Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes^†‡§

• Pages: 31-42
• First Published: 05 December 2012

Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts^{† ‡}

• Pages: 43-53
• First Published: 04 January 2013

The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States^†‡

• Pages: 54-64
• First Published: 06 February 2013

Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution^†

• Pages: 65-72
• First Published: 27 February 2013

Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance^†‡

• Pages: 73-85
• First Published: 27 February 2013

The antimalarial ferroquine is an inhibitor of hepatitis C virus^†‡

• Pages: 86-97
• First Published: 24 January 2013

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection^†

• Pages: 98-107
• First Published: 05 December 2012

Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice^†‡

• Pages: 108-119
• First Published: 13 February 2013

Intestinal microbiota in patients with nonalcoholic fatty liver disease^†‡

• Pages: 120-127
• First Published: 11 February 2013

Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice^†‡

• Pages: 128-138
• First Published: 12 January 2013

Impairment of CD4⁺ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma^†‡

• Pages: 139-149
• First Published: 07 September 2012

Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma^†‡§

• Pages: 150-157
• First Published: 06 February 2013

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway^†‡

• Pages: 158-170
• First Published: 06 February 2013

Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma^{† ‡}

• Pages: 171-181
• First Published: 06 February 2013

Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520^†‡

• Pages: 182-191
• First Published: 06 February 2013

Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis^†‡

• Pages: 192-204
• First Published: 19 February 2013

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma^†‡

• Pages: 205-217
• First Published: 11 February 2013

Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course^†‡

• Pages: 218-228
• First Published: 27 February 2013

Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification^†‡

• Pages: 229-238
• First Published: 05 March 2013

Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma^†‡

• Pages: 239-250
• First Published: 04 March 2013

GABA induces the differentiation of small into large cholangiocytes by activation of Ca²⁺/CaMK I-dependent adenylyl cyclase 8^†‡§

• Pages: 251-263
• First Published: 06 February 2013

Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study^†‡§

• Pages: 264-272
• First Published: 13 February 2013

Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study^†‡§

• Pages: 273-283
• First Published: 07 March 2013

Taurolithocholate-induced MRP2 retrieval involves MARCKS phosphorylation by protein kinase Cϵ in HUH-NTCP Cells^†‡

• Pages: 284-292
• First Published: 19 February 2013

Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice^†‡

• Pages: 293-303
• First Published: 11 February 2013

Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure^†‡

• Pages: 304-313
• First Published: 06 February 2013

Alcohol dehydrogenase–specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis^†‡§

• Pages: 314-324
• First Published: 19 February 2013

The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus^†

• Pages: 325-336
• First Published: 07 March 2013

C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice^†‡

• Pages: 337-350
• First Published: 04 March 2013

ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury^†

• Pages: 351-362
• First Published: 13 February 2013

Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice^†‡

• Pages: 363-373
• First Published: 16 March 2013

Cellular-specific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice^†‡§

• Pages: 374-387
• First Published: 04 March 2013

High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury^†‡§¶

• Pages: 388-396
• First Published: 19 December 2012

Hepatic lentiviral gene transfer is associated with clonal selection, but not with tumor formation in serially transplanted rodents^†‡

• Pages: 397-408
• First Published: 19 December 2012

Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases^†

• Pages: 409-421
• First Published: 21 November 2012

Potential consequences of healthcare recommendations: A focus on the U.S. Preventive Services Task Force^†

• Pages: 422-427
• First Published: 04 March 2013

New horizons in hepatitis C antiviral therapy with direct-acting antivirals^†

• Pages: 428-438
• First Published: 06 March 2013

Interferon-lambda polymorphisms and hepatitis C virus clearance revisited^†

• Pages: 439-441
• First Published: 08 April 2013

Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia^†

• Pages: 442-445
• First Published: 17 May 2013

Now you see it, now you don't^†

• Pages: 446-447
• First Published: 04 April 2013

B-cell frequency in hepatitis C virus-related mixed cryoglobulinemia^†

• Page: 448
• First Published: 30 October 2012

Reply: B-cell frequency in HCV-related mixed cryoglobulinemia^†

• Pages: 448-449
• First Published: 30 October 2012

3 Tesla diffusion-weighted MRI for assessing liver fibrosis in nonalcoholic fatty liver disease^†

• Pages: 449-450
• First Published: 08 January 2013

Bayesian prediction for liver fibrosis staging: Combined use of elastography and serum fibrosis markers^†

• Pages: 450-451
• First Published: 21 November 2012

Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs^†

• Pages: 451-452
• First Published: 21 November 2012

The role of biopsy of the nontumorous liver parenchyma in patients considered for partial resection of small hepatocellular carcinoma^†

• Page: 452
• First Published: 12 January 2013

• Pages: 452-453
• First Published: 12 January 2013